MADRID – On Thursday, Grifols (NASDAQ: GRFS), the Spanish drugmaker, said it was on track to meet its targets for […]
Grifols (NASDAQ: GRFS) Reaffirms 2024 Outlook as Core Earnings Rise 27% in Q3 Read More »
LONDON – Brookfield (NYSE: BN), a Canadian fund, reaffirmed its interest in a potential takeover of Spanish drugmaker Grifols (NASDAQ:
Grifols (NASDAQ: GRFS), the Spanish drugmaker, plans to invest 360 million euros ($401.98 million) to build a new industrial plant
Grifols (NASDAQ: GRFS) to Allocate $402 Million for New Industrial Centre: Report Read More »
MADRID – Three investment funds with holdings in Spanish drugmaker Grifols (NASDAQ: GRFS) have teamed up to ask to fill
Grifols (NASDAQ: GRFS) Minority Shareholders Unite to Seek Board Representation Read More »
BARCELONA/LONDON – Canadian fund Brookfield (NYSE: BAM) is in talks with banks to raise funds for its possible takeover bid
Brookfield in Negotiations with Banks to Fund Grifols Acquisition, Sources Say Read More »
MADRID – Spanish pharmaceutical company Grifols (NASDAQ: GRFS) said on Tuesday it had written down its 2020-2023 financial records by
LONDON/MADRID/BARCELONA – The Grifols family and Canadian fund Brookfield have agreed to evaluate a possible joint takeover bid for beleaguered
Grifols (NASDAQ: GRFS) Eyes Delisting in Joint Bid from Family and Brookfield Read More »
MADRID – The Grifols family and Canadian fund Brookfield (NYSE: BAM) are in talks to launch a takeover bid for
Grifols Family and Brookfield Mulling $6 Billion Bid for Grifols (NASDAQ: GRFS) Read More »
Spanish drugmaker Grifols (NASDAQ: GRFS) has appointed Rahul Srinivasan as chief financial officer, the company said on Thursday, as the
Grifols (NASDAQ: GRFS) Appoints New Finance Chief Amid Corporate Shake-Up Read More »
Copyright © 2024 abbonews.com
